New search Hide text from Guidelines
C CARDIOVASCULAR SYSTEMThis group comprises substances used for the treatment of cardiovascular conditions.
Drugs used for the treatment of hypertension are classified in C02 - Antihypertensives, C03 - Diuretics, C07 - Beta blocking agents, C08 - Calcium channel blockers, and C09 - Agents acting on the renin-angiotensin system. For the classification of combination products of antihypertensives from different ATC groups, the following ranking should be used, from higher to lower precedence: C09, C07, C08, and C03.
C10 LIPID MODIFYING AGENTS
| The DDDs are based on the treatment of hypercholesterolemia. |
C10B LIPID MODIFYING AGENTS, COMBINATIONS
Fixed combinations of blood glucose-lowering drugs and lipid modifying agents are classified in A10B.
| For fixed combinations in C10B the DDD is based on dosing frequency only. This implies that 1 UD (1 tablet) is the DDD for all products given once daily and the DDD for products given twice daily and three times daily is 2 UD (2 tablets) and 3 UD (3 tablets) respectively. |
C10BX Lipid modifying agents in combination with other drugs
This group comprises products which contain lipid modifying agents (including combinations of various lipid modifying agents) in combination with other substances.
Combinations with e.g. ACE inhibitors, angiotensin II antagonists, calcium channel blockers or diuretics are classified in C10BX.
| ATC code | Name | DDD | U | Adm.R | Note |
| C10BX09 | rosuvastatin and amlodipine |
Last updated: 2024-01-26